Globus Medical (GMED) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Globus Medical Reports First Quarter 2016 Results
May 3, 2016 4:16 PM EDTAUDUBON, Pa., May 03, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2016.
Worldwide sales increased 5.8% as reported to $139.3 million, or 6.2% on a constant currency basisFirst quarter net income increased 13.6% to $28.0 millionFully diluted earnings per share (EPS) increased 13.2% to $0.29Non-GAAP Adjusted EBITDA was 38.2% of salesCompany reiterates 2016 guidance for sales of $583 million and EPS of $1.20David Paul, Chairman and CEO said, First quarter sales were $139.3 million, a year-over-year increase of... More
